Corona Remedies Ltd vs Rpg Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Corona Remedies Ltd is ₹ 1580 as of 19 Feb 10:41 . The P/E Ratio of Corona Remedies Ltd is 0 as of March 2023 .The P/E Ratio of RPG Life Sciences Ltd is 0 as of March 2023 . The Market Cap of Corona Remedies Ltd is ₹ 0 crore as of March 2023 .The Market Cap of RPG Life Sciences Ltd is ₹ 0 crore as of March 2023 . The revenue of Corona Remedies Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 344.68 crore. This represent the decline of -100% The revenue of RPG Life Sciences Ltd for the Mar '26 is ₹ 190.39 crore as compare to the Dec '25 revenue of ₹ 183.44 crore. This represent the growth of 3.79% The ebitda of Corona Remedies Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 66.32 crore. This represent the decline of -100% The ebitda of RPG Life Sciences Ltd for the Mar '26 is ₹ 46.33 crore as compare to the Dec '25 ebitda of ₹ 34.75 crore. This represent the growth of 33.32% The net profit of Corona Remedies Ltd changed from ₹ 44.95 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of RPG Life Sciences Ltd changed from ₹ 34.93 crore to ₹ 29.9 crore over 8 quarters. This represents a CAGR of -7.48% The Dividend Payout of Corona Remedies Ltd changed from 20 % on March 2023 to 30 % on March 2025 . This represents a CAGR of 14.47% over 3 yearsThe Dividend Payout of RPG Life Sciences Ltd changed from 29.77 % on March 2021 to 21.66 % on March 2025 . This represents a CAGR of -6.16% over 5 years .

About Corona Remedies Ltd

Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited', a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli.
Thereafter, Company converted into a public limited and Company name has changed to CORONA Remedies Limited'.
A fresh certificate of incorporation, is issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024. The manufacturing facilities of the Company are located at Solan (Himachal Pradesh) and at Bhayla (Ahmedabad, Gujarat).
The Company is engaged in manufacturing, trading and marketing of Pharmaceutical products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. In 2004, Company launched the first division, and later named it as Pioneer' division in year 2010; launched Xemx (multispeciality) division in 2005.

About RPG Life Sciences Ltd

RPG Life Sciences Limited, formerly known as Searle India Limited, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group.
The Company is engaged in manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). RPG Life Sciences Limited was incorporated on March 29, 2007 with the name 'RPG Pharmaceuticals Limited'.
During the year 2007-08, as per the Scheme of Arrangement, the Company acquired the Pharmaceuticals Business of Brabourne Enterprises Limited along with all assets and liabilities pertaining to that business with effect from April 2, 2007.
On February 13, 2008, the name of the Company was changed to RPG Life Sciences Limited. During the year 2008-09, the company increased the production capacity of Bulk Drugs and Chemicals from 62 tonnes to 71 tonnes.

FAQs for the comparison of Corona Remedies Ltd and RPG Life Sciences Ltd

Which company has a larger market capitalization, Corona Remedies Ltd or RPG Life Sciences Ltd?

Market cap of Corona Remedies Ltd is 10,718 Cr while Market cap of RPG Life Sciences Ltd is 3,837 Cr

What are the key factors driving the stock performance of Corona Remedies Ltd and RPG Life Sciences Ltd?

The stock performance of Corona Remedies Ltd and RPG Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Corona Remedies Ltd and RPG Life Sciences Ltd?

As of May 5, 2026, the Corona Remedies Ltd stock price is INR ₹1752.55. On the other hand, RPG Life Sciences Ltd stock price is INR ₹2320.5.

How do dividend payouts of Corona Remedies Ltd and RPG Life Sciences Ltd compare?

To compare the dividend payouts of Corona Remedies Ltd and RPG Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.